Guo et al. (2013) found that combining H-FABP and VEGF in cerebrospinal fluid (CSF) with previously discovered markers, namely, Aβ1–42, tTau, and pTau181, is an optimal early diagnostic method for AD. The gene discussed is VEGFA; the disease is Alzheimer disease.